Diabetic Retinopathy Screening: Timing, Exams, and Treatment
A source-grounded guide to screening schedules by diabetes type, dilated examination, additional imaging, and treatment options.
Publication & corrections: infostoa · Editorial standards
Individual author and specialist reviewer information is not provided for this article.
1. Retinal changes may precede symptoms
High blood glucose can damage small retinal vessels before noticeable symptoms develop. Fluid leaking into the macula can cause swelling in the area needed for central vision; abnormal new vessels can bleed. NEI’s guidance distinguishes managing diabetes from examining the retina. Glucose management does not replace screening.
2. First examination and follow-up in U.S. adult guidance
Recommendation 12.3 in the ADA 2026 Standards of Care original text recommends an initial comprehensive dilated eye examination by an ophthalmologist or optometrist 5 years after onset of type 1 diabetes in adults. Recommendation 12.4 recommends the initial examination at diagnosis of type 2 diabetes. These are U.S. recommendations, not a replacement for local screening programs or an individual care plan. Confirm onset, previous examinations and current circumstances with the local clinician to set the schedule.
Recommendation 12.5 allows consideration of 1–2-year screening if one or more annual examinations show no retinopathy and glycemic indicators are within the goal range. Retinopathy requires at least annual examinations, with more frequent assessment for progressing or sight-threatening disease. Children and pregnancy need separate plans rather than these adult starting points alone. New visual symptoms are not a reason to wait for an initial screening date or routine interval.
3. Dilated examination and additional tests
A dilated examination uses drops to widen the pupils so the retina can be assessed. NEI describes fluorescein angiography to assess leaking vessels in severe retinopathy or suspected macular edema. This does not require identical additional imaging for every person. Ask which test was performed, what it showed and what question an additional test would answer.
4. Treatment follows the problem found
NEI describes anti-VEGF or corticosteroid injections, laser treatment and surgery among treatment options. A screening appointment does not itself mean an injection or operation is needed. Clinicians plan care around the findings and vision. Keep examination completion separate from treatment completion.
5. A record that distinguishes pending from completed
Use “diabetes type / diagnosis or onset / last comprehensive dilated examination date and clinic / result / clinician-set next assessment.” A fictional entry is “type 2 / diagnosed 16 October / previous dilated examination unknown / asked clinic about initial examination / booking confirmation pending.” An inquiry is not a completed examination. Request prior records rather than inventing an unknown date.
Do not wait for routine screening if new dark floating spots or cobweb-like streaks appear. NEI advises prompt treatment for these bleeding-related symptoms even if they clear on their own. Equally, having no symptoms is not a reason to cancel a planned examination.